What question did this study set out to answer?

To report on cases of thrombocytopenia suspected to be caused by doxycycline and underscore its monitoring during therapy.

March 8, 2026

Suspected doxycycline-induced thrombocytopenia: Two case reports and a review of the literature.

Key Points

To report on cases of thrombocytopenia suspected to be caused by doxycycline and underscore its monitoring during therapy.
Presented two case reports of patients experiencing thrombocytopenia during doxycycline treatment.
Reviewed existing literature on the adverse effects of doxycycline regarding platelet counts.
Both patients showed a decrease in platelet counts associated with doxycycline therapy.
Early detection through monitoring is crucial for timely intervention and management.

Abstract

These cases suggest that clinicians should be aware of this rare but serious adverse effect. Monitoring platelet counts during doxycycline therapy, particularly in complex patients - especially those receiving multiple medications or with underlying coagulopathy, may help with early detection and timely intervention.

Demander à l'IA

Bookmark

Cite This Study

Ling et al. (Fri,) studied this question.

synapsesocial.com/papers/69ada892bc08abd80d5bbb28 https://doi.org/https://doi.org/10.1097/md.0000000000047903

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark